Overall, this study identifies the effects and underlying mechanisms of TME stromal cells in promoting thyroid CSC aggressiveness, provides evidence suggesting that TME Akt signaling plays critical roles in driving thyroid tumor progression, and demonstrates the relevance of targeting TME Akt signaling in thyroid cancer patients. This evidence concerns the gene AKT1 and thyroid gland carcinoma.